Sara Schad

1.2k citations
7 papers · 486 · 1 hit paper · h-index 3

Impact in

  • Immunology top 10%
    • Immune cells in cancer
    • Phagocytosis and Immune Regulation
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

    • Phagocytosis and Immune Regulation 3
    • Immunotherapy and Immune Responses 3
    • CAR-T cell therapy research 3
    • Cancer Immunotherapy and Biomarkers 2

Sara Schad

6 papers receiving 484 citations

Sara Schad's Hit Papers

Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages 2017 · 432 citations
4320+3+6Years since publication100200300400

Peers

Sara Schad
Comparison fields: 5 of 52
  • Immunology 310
  • Oncology 193
  • Cancer Research 47
  • Molecular Biology 213
  • Physiology 6
Replace Alexandra L. Pourzia with:
Alexandra L. Pourzia United States
Militsa Rakina Russia
Adriana C. De La Fuente United States
М. Р. Патышева Russia
Brian E. Hsu Canada
Hester Franks United Kingdom
Allyson C. Banville Canada
Maria McSharry United States
Tania Sarkar India
David Vasquez-Dunddel United States
Sara Schad relative to Alexandra L. Pourzia United States Alexandra L. Pourzia's profile →
Citations per field
00.5×1.5×
Alexandra L. Pourzia · 1×
Citations per year

Countries citing papers authored by Sara Schad

Since Specialization
Citations

This map shows the geographic impact of Sara Schad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Schad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Schad more than expected).

Fields of papers citing papers by Sara Schad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Schad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Schad. The network helps show where Sara Schad may publish in the future.

Co-authors

The 25 scholars most cited alongside Sara Schad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sara Schad Line = papers co-authored together Sara Schad links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1
Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages
Hit paper breakdown →
2017432
2 202131
3 201519
4 20242
5 20231
6 20191
7 20200

About Sara Schad

Sara Schad is a scholar working on Immunology, Oncology, Molecular Biology, Epidemiology and Physiology, having authored 7 papers that have together received 486 indexed citations. Recurring topics across this work include CAR-T cell therapy research (3 papers), Phagocytosis and Immune Regulation (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Epigenetics and DNA Methylation (1 paper), Trace Elements in Health (1 paper), RNA Research and Splicing (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Immunology (310 citations), Oncology (193 citations), Cancer Research (47 citations), Molecular Biology (213 citations) and Physiology (6 citations). Sara Schad has collaborated with scholars based in United States. Frequent co-authors include Shawn F. Johnson, Jennifer L. Guerriero, Holly Ponichtera, Anthony Letai, Alexandra L. Pourzia, Suzan Lazo, Alaba Sotayo, Michael A. Nolan, Roderick T. Bronson and Scott Davis. Their work appears in journals such as Nature, Molecular and Cellular Endocrinology, The Journal of Immunology, Cell Reports and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact